[1] 国志, 郑芳, 赵鹏军. 癫痫伴热性惊厥病儿SCN1A、SCN2A基因突变特点及表型分析[J]. 安徽医药, 2025, 29(2): 319-324.
[2] 董晓立, 李花, 张佩琪, 等. SCN2A基因突变所致癫痫的遗传和表型特点[J]. 卒中与神经疾病, 2022, 29(3): 274-280.
[3] 孙明霞, 华颖, 王艳萍, 等. 1例SCN2A基因突变早发癫痫性脑病的诊断及治疗[J]. 山东医药, 2022, 62(9): 66-68.
[4] ZENG Q, YANG Y, DUAN J, et al. SCN2A-related epilepsy: the phenotypic spectrum, treatment and prognosis[J]. Front Mol Neurosci, 2022, 15: 809951. doi:  10.3389/fnmol.2022.809951
[5] PATEL N, MADI P, MONTEIRO I, et al. The anesthetic management of a child with ohtahara syndrome and severe stridor: a case report[J]. BMC Pediatrics, 2024, 24(1): 434. doi:  10.1186/s12887-024-04907-8
[6] MOON JU, CHO KO. Current pharmacologic strategies for treatment of intractable epilepsy in children[J]. International Neurourology Journal, 2021, 25(Suppl 1): S8-18.
[7] FALLAH MS, EUBANKS JH. Seizures in mouse models of rare neurodevelopmental disorders[J]. Neuroscience, 2020, 445: 50-68. doi:  10.1016/j.neuroscience.2020.01.041